Atlas Trials

Adaptive Treatment for Acute Myeloid Leukemia Based on D14 MRD Results

Clinical trial NCT05736978 · RECRUITING

Trial details

NCT number
NCT05736978
Sponsor
Shanghai Tong Ren Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
AMLMRD
Start date
2023-03-31
Primary completion
2025-03-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.